Prepartum application of internal teat sealant or intramammary amoxicillin on dairy heifers: Effect on udder health, survival, and performance

Intramammary infusion of antimicrobials (IA) and application of an internal teat sealant (ITS) at the end of the lactation is a common strategy to prevent and treat intramammary infections during the dry period. In heifers, precalving IA has been reported to improve udder health and milk quality; however, the effect of ITS in heifers housed in freestall barns is still unknown. The objective of this study was to investigate the effect of prepartum application of ITS or IA on udder health of dairy heifers. A total of 886 heifers were randomly allocated into 1 of 4 treatment groups when they were 245 ± 3 d pregnant. Control heifers (CON) did not receive any treatment. Heifers in the ITS group received the application of ITS containing 2.6 g of bismuth subnitrate. Animals in the IA group received intramammary administration of 62.5 mg of amoxicillin. Heifers in IA+ITS group received intramammary administration of amoxicillin followed by ITS application. The follow-up period was 270 d in milk (DIM). Clinical mastitis was diagnosed and treated by trained farm personnel throughout the study period. Composite milk somatic cell counts (SCC) were determined monthly for the first 9 mo of lactation by Dairy Herd Improvement Association. Subclinical mastitis was defined as a cow having a SCC >200,000 cells/mL for at least 1 test day and not diagnosed with clinical mastitis during the study period. At 7 ± 3 DIM, composite milk samples were collected for bacteriological analysis for a subset of the study animals. The presence of pathogens in milk at 7 ± 3 DIM was more frequently detected in the CON heifers compared with animals enrolled in the treatment groups. Heifers in IA+ITS group had a decreased incidence of clinical mastitis compared with CON heifers (12.9 vs. 21.4%). Additionally, the incidence of subclinical mastitis was decreased for IA+ITS heifers compared with CON counterparts (20.1 vs. 43.8%). During the first 9 mo of lactation, IA and IA+ITS heifers had lower SCC linear scores compared with ITS and CON counterparts. Although IA+ITS treatment successfully improved udder health, it did not result in better milk yield, fertility, and survivability. In conclusion, ITS alone was not effective in improving udder health; however, the combination of ITS and IA decreased the incidence of clinical and subclinical mastitis during the first 9 mo of lactation. Additionally, IA+ITS had a long-term effect on the SCC linear score throughout the study period.

Evaluation of the composite milk somatic cell count as a predictor of intramammary infection in dairy cattle

The objectives of this study were (1) to evaluate the test characteristics and predictive values of quarter-composite milk somatic cell count (quarter-cSCC) values based on either a single observation or the geometric mean of multiple recordings as a predictor of intramammary infection (IMI) in lactating dairy cows; and (2) to explore to what extent herd prevalence of IMI and cow factors such as parity and stage of lactation affect them. A total of 780 single-quarter milk samples were collected from 195 dairy cows for bacteriologic culture at a single cross-sectional herd screening performed at 21 different dairy herds as part of different research projects. Additionally, monthly quarter-cSCC milk samples at test day were available as part of the Dairy Herd Improvement program. Sensitivity (Se), specificity (Sp), positive predictive valu (PPV), and negative predictive value (NPV) were calculated to differentiate cows infected with any pathogen and cows infected with major pathogens from uninfected cows. Different threshold values for quarter-cSCC, ranging between 50,000 and 500,000 cells/mL, were evaluated for all animals in the study, as well as for high- and low-prevalence herds, heifers and multiparous cows, and cows in early, mid, and late lactation. The overall Se and Sp at a threshold of 200,000 cells/mL for a single quarter-cSCC observation obtained closest to the time of bacteriologic culture were 44.3 and 87.3%, respectively, for cows infected with any pathogen, and 65.1 and 73.0%, respectively, for cows infected with major pathogens. The overall PPV and NPV at a threshold of 200,000 cells/mL for a single quarter-cSCC observation obtained closest to the time of bacteriologic culture were 89.9 and 38.1%, respectively, for cows infected with any pathogen, and 40.6% and 88.1%, respectively, for cows infected with major pathogens. No major differences were observed between estimates of the test characteristics and predictive values of the quarter-cSCC criteria based on a single observation and the geometric mean of multiple observations. For IMI with any pathogen, the Se and PPV were higher in high-prevalence herds than in low-prevalence herds, particularly at thresholds of 50,000 and 100,000 cells/mL. For IMI with major pathogens, Sp was substantially higher in low-prevalence herds than in high-prevalence herds. Sensitivity was higher in multiparous cows than in heifers infected with any pathogen, more specifically at a threshold of 100,000 and 200,000 cells/mL. For cows in early and mid lactation infected with any pathogen, Sp was higher than for cows in late lactation using the single observation closest to the time of bacteriologic culture. The results suggest that the quarter-cSCC threshold value to select cows for bacteriologic culture to maximize the likelihood of finding the causative pathogen of IMI should depend on the group of pathogens one is interested in, the herd prevalence of subclinical mastitis, lactation stage, and the cow's parity.

Pathogen group-specific risk factors for intramammary infection in treated and untreated dairy heifers participating in a prepartum antimicrobial treatment trial

Heifer mastitis is a well-known problem, with several pathogens being involved. Several generic risk factors associated with the likelihood of intramammary infections (IMI) in fresh dairy heifers have been identified before. Yet, a need exists to identify pathogen group-specific factors, as the effect of (groups of) pathogens on udder health and milk yield is different. The aim of the present study was to identify pathogen group-specific risk factors for IMI in heifers participating in a prepartum antimicrobial treatment trial, allowing us to test the hypothesis that different factors are of importance between treated and untreated control heifers as well. Data from a clinical trial in which end-term heifers were treated systemically (over 3 consecutive days) 2 wk before calving with penethamate hydriodide (n=76) or remained untreated (n=73), were available. Several potential risk factors at the herd, heifer, and quarter level were recorded in the first 3 d in milk. Quarters from untreated heifers supplemented with ≥4 mg of selenium/d prepartum were significantly less likely to be infected with coagulase-negative staphylococci (CNS), whereas quarters were more likely to be infected with CNS when assistance during calving was needed. Udder edema before calving significantly decreased the odds of IMI with major pathogens. In treated heifers, no factors were detected that were associated with the likelihood of CNS IMI, whereas quarters from heifers were significantly more likely to be infected with major pathogens when they were housed in the calving pen more than 1 d and when they had been in contact with the lactating cows before calving. The risk factors for IMI that were identified in treated heifers were different than those in untreated heifers, independent of the pathogen group that was considered. It looks as if prepartum treatment not only changed the likelihood of infection, but also the factors that were associated with infection. However, except for treated heifers with an IMI with major pathogens, only a small proportion of the variation could be explained in the final models. Therefore, factors other than those that were studied could explain the likelihood of infection.